GSK Recalls Panadol Advance Bottles for Non-Child-Resistant Packaging
GSK is recalling Panadol Advance pain relievers sold in Puerto Rico because the bottles do not meet child-resistant closure requirements.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall addresses a packaging compliance issue (failure to meet child-resistant closure requirements) with no reported injuries, fitting the criteria for moderate severity involving low-risk contamination or voluntary precautionary measures.
Plain-English summary
GlaxoSmithKline (GSK) is recalling approximately 10,600 bottles of Panadol Advance 100 count caplets. The recall is due to the packaging failing to meet the child-resistant closure requirements mandated by the Poison Prevention Packaging Act. The affected products contain acetaminophen, which requires child-resistant packaging.
The recalled medicine was sold in white containers with a blue label inside a blue box. The products were sold exclusively in Puerto Rico at drug, grocery, and mass merchandise stores from November 2012 through February 2014 for about $10. The specific lot numbers included in the recall are 14241 (expiration 02/2015), 14002 (expiration 10/2014), 13881 (expiration 09/2014), and 13801 (expiration 09/2014).
No injuries have been reported. Consumers should immediately place the product out of a child's sight and reach. They should contact GSK toll-free at (888) 912-8455 from 9 a.m. to 5 p.m. ET Monday through Friday, or visit www.us.gsk.com to request a refund.
The recalled product
- Product
- Panadol Advance® 100 count caplets
- Manufacturer
- GlaxoSmithKline (GSK), of Moon Township, Penn.
- Category
- Drug — Pain Relievers
- Affected units
- 10,600
Distribution
Distributed nationwide across the United States.
Related recalls
Same hazard · packaging defect
See all →- HighMD Wipe Outz Numbing Tattoo Wipes Recalled for Child Poisoning Risk
CPSC · 2026-08-27
- SevereDermalon Sutures Recalled for Potential Sterile Barrier Packaging Defects
FDA (Devices) · 2026-08-19
- HighV-Loc 90 Absorbable Wound Closure Devices Recalled for Packaging Defects
FDA (Devices) · 2026-08-19
- HighV-Loc 180 Absorbable Wound Closure Device Recalled for Packaging Defects
FDA (Devices) · 2026-08-19
- HighBiopsy Forceps Recall: Sterile Packaging Breach Risk
FDA (Devices) · 2026-08-12